Izindaba
Breast cancer breakthrough in gene profilings?
Abstract
One in three breast cancer patients can be spared debilitating chemotherapy by a prognostic molecular test that identifies groups of genes governing metastatic dissemination, a group of Cape Town oncologists say.
The activity of groups of genes governing the process of metastasis is distilled into ‘transcriptional profiles’. Examples of these include the MammaPrint test of The Netherlands Cancer Institute, the Oncotype Dx test (USA) and the Rotterdam Profile (University of Rotterdam).
The activity of groups of genes governing the process of metastasis is distilled into ‘transcriptional profiles’. Examples of these include the MammaPrint test of The Netherlands Cancer Institute, the Oncotype Dx test (USA) and the Rotterdam Profile (University of Rotterdam).
Author's affiliations
Chris Bateman, HMPG
Full Text
PDF (96KB)Keywords
Breast cancer, transcriptonal profiling, matastasis, gene profiling.
Cite this article
South African Medical Journal 2009;99(11):780.
Article History
Date submitted: 2009-10-05
Date published: 2009-11-04
Date published: 2009-11-04
Article Views
Abstract views: 2510
Full text views: 1228
Full text views: 1228
Comments on this article
*Read our policy for posting comments here